REFERENCES
- Smith J.M., Dodd T.R.P. Adverse Reactions to Pharmaceutical Excipients. Adv. Drug React. Acute Poisoning Rev. 1982; 1: 93–142
- Golightly L.K., Smolinske S.S., Bennett M.L., Sutherland E.W., III, Rumac B.H. Pharmaceutical Excipients: Adverse Effects Associated with “Inactive” Ingredients in Drug Products (Part I). Med. Toxicol. 1988; 3: 128–165
- Golightly L.K., Smolinske S.S., Bennett M.L., Sutherland E.W., III, Rumac B.H. Pharmaceutical Excipients: Adverse Effects Associated with “Inactive” Ingredients in Drug Products (Part II). Med. Toxicol. 1988; 3: 209–240
- “Inactive” Ingredients in Pharmaceutical Products. Pediatrics 1985; 76: 635–643
- Boxenbaum H., DiLea C. First-Time-In-Human Dose Selection: Allometric Thoughts and Perspectives. J. Clin. Pharmacol. 1995; 35: 957–966
- Mouro A., Mehta D. Are Single-Dose Toxicology Studies in Animals Adequate to Support Single-Doses of a New Drug in Humans?. Clin. Pharmacol. Ther. 1996; 59: 258–264
- Hrudey S.E., Chen W., Rousseaux C.G. Bioavailability in Environmental Risk Assessment. Lewis Publishers/CRC Press, Boca Raton, FL 1996; 7–73
- Charnick S.B., Kawai R., Nedelman J.R., Lemaire M., Niederberger W., Sato H. Perspectives in Pharmacokinetics: Physiologically Based Pharmacokinetic Modeling as a Tool for Drug Development. J. Pharmacokinet. Biopharm. 1995; 23: 217–229
- Bishoff K.B., Dedrick R.L., Zaharko D.S., Longstreth J.A. Methotrexate Pharmacokinetics. J. Pharm. Sci. 1971; 60: 1128–1133
- Leung H-W. Use of Physiologically Based Pharmacokinetic Models to Establish Biological Exposure Indexes. Am. Ind. Hyg. Assoc. J. 1992; 53: 374–376
- Exposure Factors Handbook. Office of Health and Environmental Assessment, Washington, DC 1997, USEPA/600-1/8-89/043
- National Health and Nutrition Examination Survey, 1988–1991 (NHANES III), Version I. National Center for Health Statistics: Hyattsville, MD, 1995.
- Stella V.J., Rajewski R.A. Cyclodextrins: Their Future in Drug Formulation and Delivery. Pharm. Res. 1997; 14: 556–567
- Boulder M.E. HFC 134a: The Latest in Propellant Alternatives. Spray Technol. Market 1994; August: 32–35
- Illum L. Chitosan and Its Use as a Pharmaceutical Excipient. Pharm. Res. 1998; 15: 1326–1331
- Ghosh T.K., Banga A.K. Methods of Enhancement of Transdermal Drug Delivery: Part IIA, Chemical Permeation Enhancers. Pharmacol. Technol. 1993; April: 62–89
- Barksdale H.C., Jr, Goldstucker J.L. Marketing Information: A Professional Reference Guide. 3rd Ed., Georgia State University Business Press, Atlanta, GA 1995
- PMD: Pharmaceutical Marketers Directory. CPS Communications: Boca Raton, FL, 1998.
- Guiding Principles for Monte Carlo Analysis. Risk Assessment Forum, Washington, DC 1998, EPA/630/R-97/001
- Bourgoin B.P., Evans D.R., Cornett J.R., Lingard S.M., Quattrone A.J. Lead Content in 70 Brands of Dietary Calcium Supplements. Am. J. Public Health 1993; 83: 1155–1160
- The National Dioxin Study Report to Congress. 1987, September 24
- Harvey D.C., Chou H.J. N-Nitrosamines in Cosmetic Products: An Overview. Cosmet. Toil. 1994; 109: 53–62
- Ansel H.C., Popovich N.G., Allen L.V., Jr. Pharmaceutical Dosage Forms and Drug Delivery Systems. 6th Ed., Lea and Febiger, Malvern, PA 1995
- Dermal Exposure Assessment: Principles and Applications. Office of Health and Environmental Assessment, Washington, DC 1992, EPA/600/8-91/011B
- Methods for Derivation of Inhalation Reference Concentrations and Application of Inhalation Dosimetry. Office of Research and Development, Washington, DC 1994, EPA/600/8-90/066F
- Gardner D., Casper R., Leith F., Wilding I. Noninvasive Methodology for Assessing Regional Drug Absorption from the Gastrointestinal Tract. Pharmacol. Technol. 1997; Oct: 82–89
- Burch A., Barr W.H. Absorption of Propranolol in Humans Following Oral, Jejunal, and Ileal Administration. Pharm. Res. 1998; 15: 953–957
- Guy R.H., Guy A.H., Moibach H.I., Shah V.P. The Bioavailability of Dermatological and Other Topically Administered Drugs. Pharm. Res. 1986; 3: 253–262
- Dermal Absorption and Toxicity Assessment, M.S. Roberts, K.A. Walters. Marcel Dekker, NewYork 1998
- Physicians Desk Reference for Nonprescription Drugs, Medical Economics: Advil Monograph. Montvale, NJ, 1998, p. 428.
- Rock, P.C. International Pharmaceutical Aerosol Consortium for Toxicity Testing Secretariat, Washington, DC, personal communication, 1998.